![Nicolas Moliner Rezola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicolas Moliner Rezola
Analyste en capital-investissement chez
Altamar Private Equity SGIIC SA /Private Equity/
Profil
Nicolas is Associate in the Credit team, having joined the company as an Analyst in 2018.
Prior to Altamar, he worked for seven months in the Special Situations team at Tikehau Capital (London).
Before that, he worked for one year in the M&A team at Houlihan Lokey (Madrid).
Nicolás holds a Bachelor of Business Administration and Management, from CUNEF
Postes actifs de Nicolas Moliner Rezola
| Sociétés | Poste | Début |
|---|---|---|
Altamar Private Equity SGIIC SA /Private Equity/
 Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity invests in companies located across the globe. The firm targets businesses operating in the life sciences sector including biotechnology, infrastructure, medical devices, diagnostics, genomics, and digital health. It provides equity and debt financing for buyouts, secondary, special situations, and early to growth stage capital requirements. It also makes co-investments. | Analyste en capital-investissement | 01/04/2018 |
Formation de Nicolas Moliner Rezola
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Colegio Universitario de Estudios Financieros
 Colegio Universitario de Estudios Financieros Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altamar Private Equity SGIIC SA /Private Equity/
Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity invests in companies located across the globe. The firm targets businesses operating in the life sciences sector including biotechnology, infrastructure, medical devices, diagnostics, genomics, and digital health. It provides equity and debt financing for buyouts, secondary, special situations, and early to growth stage capital requirements. It also makes co-investments. | Finance |
